Atrandi Biosciences logo
Biotech/Pharma
Data/Analytics
HealthTech

Atrandi Biosciences

Advanced single-cell analysis technologies

CORE INFO

$25M
Total Funding
Series A
Round
2016
Founded
74
Team Size
Vilnius, Lithuania
Headquarters

Atrandi Biosciences provides advanced single-cell analysis technologies, offering platforms like Onyx, Styx, and Flux to research institutions and laboratories for high-throughput droplet and Semi-Permeable Capsule (SPC) workflows.

  • Atrandi Biosciences raised $25 million in a Series A funding round led by Lux Capital in February 2025.globenewswire.com
  • The company's technology is utilized by over 200 research groups worldwide, with more than 150 instruments deployed globally.atrandi.com
  • Business Wire reported on Atrandi's $4.8 million funding round in March 2023, highlighting their plans for global commercialization.businesswire.com

WHY WE WOULD WORK AT ATRANDI BIOSCIENCES

Empowering Scientific Discovery

Join a mission-driven team dedicated to empowering scientists with advanced single-cell analysis technologies, enabling groundbreaking discoveries in biology.

Innovative Technology

Work with cutting-edge platforms like Onyx, Styx, and Flux, designed for high-throughput droplet and Semi-Permeable Capsule workflows.

Collaborative Culture

Be part of a dynamic team of 74 professionals who value innovation, ownership, and perseverance, fostering a collaborative and supportive work environment.

Competitive Compensation

Benefit from a strong funding foundation with over $33.8 million raised, ensuring competitive salaries and resources for employee growth.

Global Impact

Contribute to a company whose technology is utilized by over 200 research groups worldwide, making a significant impact in life sciences and biotechnology.

Career Growth Opportunities

With recent Series A funding of $25 million, Atrandi is poised for expansion, offering ample opportunities for professional development and career advancement.

MARKET AND TRACTION

TOTAL ADDRESSABLE MARKET

  • Atrandi Biosciences operates in the life sciences and biotechnology sectors, focusing on single-cell analysis technologies.

  • The demand for advanced single-cell analysis is growing, driven by the need for precision in biological research and multiomics applications.
  • KEY METRICS

    ✦ KEY METRIC
  • Atrandi has secured over $33.8 million in total funding, with a significant $25 million Series A round completed in February 2025.

  • The company has deployed more than 150 instruments globally, serving over 200 research groups worldwide.
  • NOTABLE CUSTOMERS

  • Atrandi's technology is utilized by over 200 research groups, including partnerships with more than 20 institutions.

  • Their products cater primarily to research institutions and laboratories focused on single-cell analysis.
  • GROWTH TACTICS

  • Atrandi aims to expand its market presence in the U.S. following its recent funding round.

  • The company focuses on advancing its Semi-Permeable Capsule (SPC) technology to enhance single-cell workflows.
  • COMPETITIVE ADVANTAGE

  • Atrandi's innovative platforms, such as Onyx, Styx, and Flux, are designed for high-throughput workflows, setting them apart in the single-cell analysis market.

  • Their commitment to empowering scientists with advanced tools for biological data interpretation positions them as leaders in their field.
  • PRODUCT AND TECH

    Onyx Platform

    Onyx is a high-throughput droplet microfluidics platform designed for advanced single-cell analysis, enabling researchers to conduct complex experiments with unprecedented precision and scalability.

    Styx Platform

    Styx offers innovative capabilities for droplet-based workflows, enhancing the efficiency of single-cell analysis and allowing for detailed exploration of cellular heterogeneity.

    Flux Technology

    Flux technology provides a streamlined approach to semi-permeable capsule workflows, facilitating the encapsulation and analysis of various cell types in a high-throughput manner.

    SPC Innovator Kits

    These kits are designed to support multi-step single-cell workflows, empowering research institutions and laboratories to perform comprehensive analyses of biological samples.

    Semi-Permeable Capsule Technology

    This cutting-edge technology enables the encapsulation of cells in a controlled environment, allowing for precise manipulation and analysis of single cells, which is crucial for understanding biological complexity.

    COMPANY CULTURE

    Values

  • Innovation drives our technology and solutions.

  • Ownership fosters accountability and responsibility.

  • Perseverance is key to overcoming challenges in research.
  • Operating Principles

  • Collaboration among team members enhances creativity.

  • Data-driven decision making guides our strategies.

  • Continuous improvement is essential for growth and success.
  • Benefits

  • Opportunities for professional development and training.

  • Access to cutting-edge technology and resources.

  • Supportive work environment that encourages experimentation.
  • Team Cadence

  • Regular team meetings to align on goals and progress.

  • Open communication channels for feedback and ideas.

  • Agile project management to adapt to changing research needs.
  • Learning & Growth

  • Emphasis on knowledge sharing and mentorship.

  • Encouragement to pursue innovative research projects.

  • Access to industry conferences and workshops for skill enhancement.
  • HIRING SIGNAL

    0
    Open roles on their careers page
    Snapshot via live ATS poll
    —
    Net new roles in the last 90 days
    Available once weekly history accrues
    90-Day VelocityV2 · BACKFILL
    Trend builds weekly as historical rows accrue
    SourcesGreenhouseLeverAshbyWorkableSmartRecruitersRipplingRecruiteeFallback · Wellfound, YC Work-at-a-Startup, careers-page scrape

    KEY COMPANY ANNOUNCEMENTS

    Filter
    9 announcements · ranked by importance
    Feb 20, 2025FUNDING25 milijonų investiciją gavęs lietuvių startuolis: JAV niekas nieko ant lėkštutės nepadedalrt.lt
    Mar 28, 2023FUNDINGAtrandi Biosciences Secures Funding and Advances Global Commercialization of Next-Gen Single Cell Analysis Technologybusinesswire.com
    Jan 1, 2024CUSTOMER WINInnovating together: Atrandi Biosciences advancing single-cell analysis with the help of custom OEM solutionsassets.thermofisher.com
    May 19, 2026EXEC HIREWelcoming Sam Ropp and Susan Tousi to Atrandiatrandi.com
    Oct 25, 2021PRESSHow Lithuanian and German scientists are making research more accessibleinovacijuagentura.lt
    Aug 29, 2023INTERVIEWEp 128: Juozas Nainys — The Pursuit of Scrappiness Podcastpursuitofscrappiness.co
    May 15, 2026INTERVIEWInterview with Rapolas Žilionisprecisionmedicine.lifesciencexchange.com
    Jan 1, 2026CUSTOMER WINBringing the Invisible to Light: Bigelow Scientists Find Unexpected Viral Members of Ocean Communityatrandi.com
    Dec 29, 2023CUSTOMER WINAtrandi Biosciences and Suremedical Join Forces for South Korean Expansionatrandi.com